Ivabradine: pre-clinical and clinical evidence in the setting of ventricular arrhythmias.

Bazoukis, G; Hill, B; Tse, G; Naka, K K

Bazoukis, G; Hill, B; Tse, G; Naka, K K.

Afiliação

Bazoukis G; Department of Cardiology, Larnaca General Hospital, Larnaca, Cyprus.
Hill B; Department of Basic and Clinical Sciences, University of Nicosia Medical School, Nicosia, Cyprus.
Tse G; Department of Medicine, Queen's University, Kingston, Ontario, Canada.
Naka KK; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China.

Hippokratia ; 26(2): 49-54, 2022.

Article em En | MEDLINE | ID: mdl-37188047

Palavras-chave

Ivabradine; ventricular arrhythmias; ventricular tachycardia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline Idioma: En Ano de publicação: 2022 Tipo de documento: Article